VRCA
Verrica Pharmaceuticals Inc
NASDAQ: VRCA · HEALTHCARE · BIOTECHNOLOGY
$6.37
-3.19% today
Updated 2026-04-30
Market cap
$112.18M
P/E ratio
—
P/S ratio
3.15x
EPS (TTM)
$-1.68
Dividend yield
—
52W range
$3 – $10
Volume
0.1M
Verrica Pharmaceuticals Inc (VRCA) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+92.3%
Last 4 quarters
Revenue YoY growth
+1380.2%
Most recent quarter
EPS YoY growth
-153.4%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-0.4%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-3.6%
2025-11-14
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-11 | $-0.51 | +20.3% | $5.98 | $6.15 | +2.8% |
| 2025-11-14 | $0.13 | +262.5% | $3.87 | $3.73 | -3.6% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.64 | $-0.51 | +20.3% | $5.09M | +1380.2% |
| 2025-09-30 | $-0.08 | $0.13 | +262.5% | $14.34M | -905.4% |
| 2025-06-30 | $-0.09 | $0.02 | +122.2% | $12.70M | +145.4% |
| 2025-03-31 | $-0.14 | $-0.10 | +26.5% | $3.44M | -10.1% |
| 2024-12-31 | $-0.24 | $-0.20 | +16.8% | $344000.00 | -82.7% |
| 2024-09-30 | $-0.37 | $-0.49 | -32.4% | $-1.78M | -161.1% |
| 2024-06-30 | $-0.42 | $-0.37 | +11.9% | $5.18M | +2744.5% |
| 2024-03-31 | $-0.40 | $-0.44 | -10.0% | $3.83M | +10240.5% |
| 2023-12-31 | $-0.53 | $-0.53 | +0.0% | $1.99M | — |
| 2023-09-30 | $-0.36 | $-0.54 | -50.0% | $2.92M | — |
| 2023-06-30 | $-0.21 | $-0.24 | -14.3% | $182000.00 | — |
| 2023-03-31 | $-0.19 | $-0.15 | +21.1% | $37000.00 | — |
Frequently asked questions
Has Verrica Pharmaceuticals Inc beaten earnings estimates?
Verrica Pharmaceuticals Inc has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +92.3% over the last 4 quarters.
How does VRCA stock react to earnings?
VRCA stock has moved an average of -0.4% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Verrica Pharmaceuticals Inc's revenue growth rate?
Verrica Pharmaceuticals Inc reported year-over-year revenue growth of +1380.2% in its most recent quarter, with EPS growing -153.4% year-over-year.